The FDA is working to increase access and lower the cost of the lifesaving opioid overdose antidote naloxone by making it easier for drugmakers to produce over-the-counter versions of the medication.
Pharmacy
Retail pharmacy chain Rite Aid will pay $177,000 to resolve allegations that it violated Massachusetts law by accepting cash payments from Medicaid recipients for controlled substances instead of billing the agency "in a limited number of instances," according to The…
Becker's Hospital Review has reported five drug company layoffs in the last two weeks. They are listed below, beginning with the most recent.
After spending more than 10 years with Methodist Dallas Medical Medical Center as vice president of operations and director of pharmacy, Jon Albrecht, RPh, was appointed to vice president of pharmacy for the Methodist Health System in summer of 2018.
Steve Ubl, CEO of the Pharmaceutical Research and Manufacturers of America, said he remains "hopeful" the Trump administration will reconsider its proposal to lower drug prices, according to The Hill.
Advertisement
Allergan and the St. Regis Mohawk Tribe will continue their legal battle in defense of a patent agreement struck in 2017, appealing a lower court decision to the U.S. Supreme Court, according to STAT.
Purdue Pharma formed relationships with two Boston-based organizations — Massachusetts General Hospital and Tufts University School of Medicine — to boost prescription rates and generate goodwill toward opioids as painkillers, according to a court filing released Jan. 15.
Pharmedium, AmerisourceBergen's troubled compounding unit, will lay off 225 workers at its Memphis, Tenn., facility by March 12, according to the Commercial Appeal.
Pfizer is ending five preclinical programs in its biosimilar research and development unit, which will result in 150 employees losing their jobs, according to a BioSpace news report.
CVS has already sent shockwaves through the healthcare industry with its first-of-a-kind merger with health insurer Aetna — but its path to transforming healthcare won't stop there, CVS CEO Larry Merlo said at a National Press Club luncheon Jan. 14,…